Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro

被引:101
作者
Fioravanti, L
Cappelletti, V
Miodini, P
Ronchi, E
Brivio, M
Di Fronzo, G
机构
[1] Ist Nazl Studio & Cura Tumori, I-20133 Milan, Italy
[2] CNR, Ctr Res Cell Pathol, I-20133 Milan, Italy
关键词
breast cancer; cell cycle; estradiol; genistein; growth factors; tyrosine kinase inhibitors;
D O I
10.1016/S0304-3835(98)00130-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Genistein significantly inhibited cell growth (IC50 around 10 mu M) of MCF-7, MDAMB-231 and HBL-100 cell lines, but not of skin-derived fibroblasts and counteracted the growth-stimulatory effects exerted by estradiol and growth factors. It abolished the paracrine stimulation observed in MCF-7 cells in co-culture with MDAMB-231 or fibroblasts. Genistein-treated cells accumulated in the S and G(2)/M phases of the cell cycle and underwent apoptosis. Genistein decreased tyrosine phosphorylation induced upon treatment with transforming growth factor-alpha. Finally, genistein bound the estrogen receptor (ER) (relative affinity constant K-d = 4 nM), induced pS2 and cathepsin-D transcription and increased nuclear ER levels. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 31 条
[2]  
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[3]  
BARNES S, 1995, J NUTR, V125, pS777, DOI 10.1093/jn/125.3_Suppl.777S
[4]  
BARNES S, 1990, PROG CLIN BIOL RES, V347, P239
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   SIMULTANEOUS ESTIMATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS AND STEROID-RECEPTORS IN A SERIES OF 136 RESECTABLE PRIMARY BREAST-TUMORS [J].
CAPPELLETTI, V ;
BRIVIO, M ;
MIODINI, P ;
GRANATA, G ;
CORADINI, D ;
DIFRONZO, G .
TUMOR BIOLOGY, 1988, 9 (04) :200-211
[8]   PARACRINE INTERACTION IN COCULTURE OF HORMONE-DEPENDENT AND INDEPENDENT BREAST-CANCER CELLS [J].
CAPPELLETTI, V ;
RUEDL, C ;
MIODINI, P ;
FIORAVANTI, L ;
CORADINI, D ;
DIFRONZO, G ;
SILVESTRINI, R .
BREAST CANCER RESEARCH AND TREATMENT, 1993, 26 (03) :275-281
[9]  
COSTANTINOU A, 1995, P SOC EXP BIOL MED, V208, P109
[10]  
ERNSTER VL, 1987, J NATL CANCER I, V79, P949